Aquestive Therapeutics (AQST) PT Lowered to $21 at BMO Capital

March 15, 2019 6:51 AM

BMO Capital analyst Gary Nachman lowered the price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found